Case Reports in Surgery and Invasive Procedures

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Rapid Communication - Case Reports in Surgery and Invasive Procedures (2023) Volume 7, Issue 1

Analysis of Coronary artery bypass graft.

Grace Jawali*

Department of Pulmonary, Columbia University College of Physicians and Surgeons, New York, United States

*Corresponding Author:
Grace Jawali
Department of Pulmonary,
Columbia University College of Physicians and Surgeons,
New York, United States
E-mail:jawali@grace.edu

Received: 30-Dec-2022, Manuscript No. AACRSIP-23-85730; Editor assigned: 03-Jan-2023, PreQC No. AACRSIP-23-85730(PQ); Reviewed: 17-Jan-2023, QC No. AACRSIP-23-85730; Revised: 24-Jan-2023, Manuscript No. AACRSIP-23-85730; Published: 31-Jan-2023, DOI:10.35841/ aacrsip-7.1.135

Citation: Jawali G. Analysis of coronary artery bypass graft. Case Rep Surg Invasive Proced. 2023;7(1):135

Visit for more related articles at Case Reports in Surgery and Invasive Procedures

Abstract

CABG surgery has a rich history of successes and failures by pioneers in the field of cardiac surgery. Its development has progressed from the experimental phase through the discovery of optimal conduit selection based on patient-centered insights into the current era, where the method of performing surgery has taken center stage. The next era must focus more on optimal use of surgical and interventional resources to provide the best and least invasive long-term treatments. Boundaries may disappear in the future. CABG is an important major surgical procedure that helps prevent severe morbidity in patients' lives by relieving angina symptoms and improving quality of life. Patients receiving well-selected CABG have improved survival compared to those receiving drug therapy or PCI alone.

Keywords

Coronary artery bypass grafting, Meta-analysis, Ischemic myocardium, Antiplatelet drugs.

Introduction

Coronary Artery Bypass Grafting (CABG) is a major surgical procedure that uses a harvested venous or arterial line to bypass an atheromatous occlusion in a patient's coronary arteries. Bypass restores blood flow to the ischemic myocardium, restores function and viability, and relieves symptoms of angina. CABG surgery is performed annually; making it the most commonly performed major surgical procedure. However, the trend toward surgery is declining as medical management and the use of alternative options such as percutaneous coronary intervention increase [1].

Coronary artery disease is a public health problem and a leading cause of life loss, disability and death worldwide. The main procedure these patients undergo is cardiac catheterization, which improves quality of life, symptoms of myocardial ischemia, ventricular function, and increases survival in affected patients. However, there are also physical effects such as renal failure, acute heart attack, and stroke. The aim is analyse how CABG affects quality of life. Several subjects were included, in the systematic review and 3 in the meta-analysis. Studies that used the SF questionnaire to analyse quality of life showed improvements in the quality of physical and mental appearance and studies that used the NHP questionnaire showed improvements in scores and, in some cases, women and men. Differences in men's quality of life were demonstrated. This surgery appears to be a good choice for improving the quality of life of people with coronary artery conditions after any possible risks have been assessed [2].

The results of coronary artery bypass grafts with saphenous vein grafts are unsatisfactory because vein grafts are prone to occlusive disease. Ten years after surgery are closed, mainly due to atherosclerosis. Symptoms recur in vein graft disease and graft occlusion [3].

The best way to prevent vein graft disease is with an internal mammary artery graft. This makes it a preferred graft as it is not susceptible to atherosclerosis. The result is a much higher patency rate. This provides clinical benefits such as reduced symptom incidence, improved left ventricular function, reduced need for reoperation and increased survival. Due to the limited supply of thoracic arteries, there is growing interest in identifying alternative arterial grafts [4].

In just over a century, heart surgery went from being out of reach to being commonplace. Major advances have made CABG a safer and more acceptable procedure. On-going research into different approaches, methods, and medical interventions will make cardiac surgery less invasive and safer in the future. A team approach should be used to assess the benefits and risks of each patient to determine which method is most appropriate for that patient. Even with paradigm shifts in medicine and stenting, advances in coronary artery surgery are important for patients who cannot be treated surgically. As surgery becomes relatively rare, the question of how many future cardiac surgeons to train and how to train them can become an issue. Additionally, as procedures and patients become more complex, the development of different specialized postoperative strategies should be considered. Ultimately, the field of cardiac surgery needs to become more specialized, as it may take longer and require more procedures, including high-risk surgeries [5].

Conclusion

To prevent vein graft disease, surgeons should bypass the diseased coronary artery with at least one arterial graft and take steps to avoid endothelial injury of the vein graft during surgery. Treatment with antiplatelet drugs reduces the occlusion rate of vein grafts. If graft atherosclerosis is causing symptoms, or if the old left anterior descending coronary artery graft is diseased, revision surgery may prolong life. Reoperation increases the patient's chances of survival if the surgeon uses at least one arterial graft

.

References

  1. Suma H. The right gastroepiploic artery graft for coronary artery bypass grafting: a 30-year experience. Korean J Thorac Cardiovasc Surg. 2016;49(4):225

    2. Indexed at, Google Scholar, Cross Ref

  2. Favaloro RG. Critical analysis of coronary artery bypass graft surgery: a 30-year journey. J Am Coll Cardiol. 1998;31(4S2):1B-63B

    3. Indexed at, Google Scholar, Cross Ref

  3. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360(10):961-72

    4. Indexed at, Google Scholar, Cross Ref

  4. Sasaki H. Coronary artery bypass grafting without full sternotomy. Surg Today. 2009;39(11):929-37

    5. Indexed at, Google Scholar, Cross Ref

  5. Melly L, Torregrossa G, Lee T, et al. Fifty years of coronary artery bypass grafting. J Thorac Dis 2018;10(3):1960

    6. Indexed at, Google Scholar, Cross Ref

Get the App